Content area
Abstract
The nutrient-sensitive protein kinases AMPK and mTORC1 form a fundamental negative feedback loop that governs cell growth and proliferation. mTORC1 phosphorylates α2-S345 in the AMPK αβγ heterotrimer to suppress its activity and promote cell proliferation under nutrient stress conditions. Whether AMPK contains other functional mTORC1 substrates is unknown. Using mass spectrometry, we generated precise stoichiometry profiles of phosphorylation sites across all twelve AMPK complexes expressed in proliferating human cells and identified seven sites displaying sensitivity to pharmacological mTORC1 inhibition. These included the abundantly phosphorylated residues β1-S182 and β2-S184, which were confirmed as mTORC1 substrates on purified AMPK, and four residues in the unique γ2 N-terminal extension. β-S182/184 phosphorylation was elevated in α1-containing complexes relative to α2, an effect attributed to the α-subunit serine/threonine-rich loop. Mutation of β1-S182 to non-phosphorylatable Ala had no effect on basal and ligand-stimulated AMPK activity; however, β2-S184A mutation increased nuclear AMPK activity, enhanced cell proliferation under nutrient stress and altered expression of genes implicated in glucose metabolism and Akt signalling. Our results indicate that mTORC1 directly or indirectly phosphorylates multiple AMPK residues that may contribute to metabolic rewiring in cancerous cells.
Details
1 St. Vincent’s Institute of Medical Research, Metabolic Signalling Laboratory, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University Hospital of the Paracelsus Medical University, Research Program for Receptor Biochemistry and Tumour Metabolism, Department of Paediatrics, Salzburg, Austria (GRID:grid.21604.31) (ISNI:0000 0004 0523 5263)
2 St. Vincent’s Institute of Medical Research, Protein Engineering in Immunity and Metabolism, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
3 St. Vincent’s Institute of Medical Research, Protein Chemistry and Metabolism, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
4 St. Vincent’s Institute of Medical Research, Metabolic Signalling Laboratory, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
5 Flinders University, Flinders Health and Medical Research Institute, Flinders Centre for Innovation in Cancer, Adelaide, Australia (GRID:grid.1014.4) (ISNI:0000 0004 0367 2697)
6 St. Vincent’s Institute of Medical Research, Genome Stability Unit, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
7 St. Vincent’s Institute of Medical Research, Cancer and RNA Biology, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X)
8 St. Vincent’s Institute of Medical Research, Cancer and RNA Biology, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
9 Monash Institute of Pharmaceutical Sciences, Drug Discovery Biology, Parkville, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Australian Catholic University, Mary McKillop Institute for Health Research, Melbourne, Australia (GRID:grid.411958.0) (ISNI:0000 0001 2194 1270)
10 Monash Institute of Pharmaceutical Sciences, Drug Discovery Biology, Parkville, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Royal Parade, The Florey Institute of Neuroscience and Mental Health, Parkville, Australia (GRID:grid.418025.a) (ISNI:0000 0004 0606 5526)
11 St. Vincent’s Institute of Medical Research, Protein Chemistry and Metabolism, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Australian Catholic University, Mary McKillop Institute for Health Research, Melbourne, Australia (GRID:grid.411958.0) (ISNI:0000 0001 2194 1270)
12 St. Vincent’s Institute of Medical Research, Protein Engineering in Immunity and Metabolism, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
13 St. Vincent’s Institute of Medical Research, Metabolic Signalling Laboratory, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X)
14 St. Vincent’s Institute of Medical Research, Metabolic Signalling Laboratory, Fitzroy, Australia (GRID:grid.1073.5) (ISNI:0000 0004 0626 201X); University of Melbourne, Department of Medicine, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Australian Catholic University, Mary McKillop Institute for Health Research, Melbourne, Australia (GRID:grid.411958.0) (ISNI:0000 0001 2194 1270)